Image by dalequetepego via Flickr
In Spain the “conditions exist to perform experiments with this technique”. Health Minister Bernat Soria experienced a personal triumph with the approval of the first human testing with embryonic stem cells, even if it did occur in the US. He added that he is working on regulations “so that all of this, which is already legal, is effective in practical terms: both to provide guarantees for the researchers and volunteers and to facilitate procedures.
He also announced that his intentions have materialized in an agreement with the Governor of California, who, although a Republican,
Image via Wikipedia
Dozens of people who were blinded or otherwise suffered severe eye damage when they were splashed with caustic chemicals had their sight restored with transplants of their own stem cells — a stunning success for the burgeoning cell-therapy field, Italian researchers reported Wednesday.
The treatment worked completely in 82 of 107 eyes and partially in 14 others, with benefits lasting up to a decade so far. One man whose eyes were severely damaged more than 60 years ago now has near-normal vision.
“This is a roaring success,” said ophthalmologist Dr. Ivan Schwab of the University of California, Davis, who
In his latest defiance of the federal government, Gov. Rick Perry is trying to make Texas the nation’s top provider of an unlicensed therapy touted by some as the future of medicine but considered not close to ready for mainstream use by scientists in the field.
Perry this summer worked with his Houston doctor and a state legislator with multiple sclerosis to write legislation intended to commercialize the controversial therapy, which involves injecting patients with their own stem cells. Perry quietly got the therapy as part of back surgery in July.
“With the right policies in place, we can lead the
CRYO-SAVE Group, the Netherlands-based stem cell company with a large Indian presence, plans to increase the number of stem cell donors
in the country by opening more representative offices. The company expects this would increase the number of clients and also extend its reach beyond the current five cities, group CEO Rob Koremans told ET.
Cryo-Save Group plans to invest e 2 million (about Rs 13 crore) in its Bangalore-based subsidiary for over three years.
Stem Cell Research Trial for Congestive Heart Failure
Look what we have here- another stem cell research trial for heart disease (congestive heart failure) and another heart patient has his life improved. This time, at the University of Louisville, the first heart failure patient treated with his own Adult Stem Cells has improved already, […]